We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT01375530
Previous Study | Return to List | Next Study

Screening Volunteers for Clinical Trials

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01375530
Recruitment Status : Recruiting
First Posted : June 17, 2011
Last Update Posted : March 16, 2018
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Allergy and Infectious Diseases (NIAID) )

June 16, 2011
June 17, 2011
March 16, 2018
June 16, 2011
Not Provided
To screen subjects for their eligibility to participate in clinical trials ofinvestigational products or licensed products being evaluated for research purposes. [ Time Frame: Ongoing ]
Not Provided
Complete list of historical versions of study NCT01375530 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Screening Volunteers for Clinical Trials
VRC 500:Screening of Volunteers for Clinical Trials of Investigational Products and Licensed Products Evaluated for Research Purposes


- The National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health needs healthy volunteers for vaccine clinical trials. These trials will allow researchers to study vaccines and injection devices. These studies will also allow researchers to understand the immune system and how vaccines work. In this protocol, researchers will screen healthy volunteers for these future trials.


- To screen healthy volunteers for clinical trials at the NIAID.


- Healthy people between 18 and 70 years of age. They must be available to take part in clinical trials and be able to provide blood for research studies.


  • Screening for a clinical trial may begin several months before the vaccine clinical trial begins.
  • Volunteers will be screened with a physical exam and medical history. They may also answer questions about sexual activity and drug use.
  • Volunteers will provide blood samples and possibly urine samples. They may have other tests as needed for the study.
  • Volunteers will not receive any treatment in this screening trial.
The purpose of this study is to screen potential study volunteers to determine if they are eligible for clinical trials of investigational products conducted by the Vaccine Research Center (VRC), NIAID, NIH. Educational materials on the investigational products and protocols will be reviewed with and provided to subjects during participation in the screening protocol. Approximately 3,000 adults, ages 18-70 years, will be enrolled.
Observational Model: Other
Time Perspective: Other
Not Provided
Not Provided
Not Provided
Not Provided
Human Health
Not Provided
Not Provided
Graham BS, Ledgerwood JE, Nabel GJ. Vaccine development in the twenty-first century: changing paradigms for elusive viruses. Clin Pharmacol Ther. 2009 Sep;86(3):234-6. doi: 10.1038/clpt.2009.128.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Not Provided
Not Provided

Age: 18-70 years of age

Available to participate for the planned duration of the clinical trial for which the screening is being done

Able and willing to complete the informed consent process

Agree to have blood and/or tissue samples collected and stored for future studies of investigational products, the immune system, and/or other medical conditions


A condition in which repeated blood draws or injections pose more than minimal risk for the subject such as hemophilia, other severe coagulation disorders or significantly impaired venous access

A condition that requires active medical intervention or monitoring to avert serious danger to the participant s health or well-being

Known to be pregnant or breast-feeding

Sexes Eligible for Study: All
18 Years to 70 Years   (Adult, Senior)
Contact: Ingelise Gordon, R.N. (301) 451-8715 vaccines@nih.gov
United States
Not Provided
Not Provided
Not Provided
National Institutes of Health Clinical Center (CC) ( National Institute of Allergy and Infectious Diseases (NIAID) )
National Institute of Allergy and Infectious Diseases (NIAID)
Not Provided
Principal Investigator: Martin R Gaudinski, M.D. National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health Clinical Center (CC)
March 14, 2018